Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75
(0.63%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma receives approval for generic ‘Sofosbuvir’ tablets in India
>>
Natco Pharma shines on launching first generic version of Sofosbuvir in Nepal
>>
Natco Pharma soars on launching first generic version of Sofosbuvir in Nepal
>>
Natco Pharma launches first generic version of Sofosbuvir in Nepal
>>
Natco Pharma shines on inking nonexclusive licensing pact with Gilead Sciences
>>
Natco Pharma inks nonexclusive licensing pact with Gilead Sciences
>>
Natco Pharma declines on reporting 52% fall in Q3 consolidated net profit
>>
Natco Pharma reports 52% fall in Q3 consolidated net profit
>>
Natco Pharma shines on filing ANDA for Fingolimod with US FDA
>>
Natco Pharma files ANDA for Fingolimod with US FDA
<<
<
45
46
47
...52
>
>>